CD47/SIRPα axis: bridging innate and adaptive immunity
Myeloid immune cells are frequently present in the tumor environment, and although they can positively contribute to tumor control they often negatively impact anticancer immune responses. One way of inhibiting the positive contributions of myeloid cells is by signaling through the cluster of differ...
Saved in:
Main Authors: | Sjoerd H van der Burg, Anneloes van Duijn, Ferenc A Scheeren |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-07-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/10/7/e004589.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blocking ANGPTL3 and CD47 impact on atherosclerosis-correspondence
by: Han-Yong Hou, et al.
Published: (2025-02-01) -
Comment on “Role of CD47 Gene Expression in Colorectal Cancer: A Comprehensive Molecular Profiling Study”
by: Zhang Chongjie, et al.
Published: (2025-02-01) -
Editorial: Impact of the innate and adaptive immune system in driving type 1 inflammatory skin disease
by: Mark Mellett, et al.
Published: (2025-02-01) -
Infiltration of the liver by cells of innate and adaptive immunity and their destruction in development of experimental immune concanavalin-A-induced hepatitis
by: S. I. Pavlovich, et al.
Published: (2011-12-01) -
Frk positively regulates innate antiviral immunity by phosphorylating TBK1
by: Xiaomei Zhang, et al.
Published: (2025-02-01)